Performance and Image Enhancing Peptides - podcast episode cover

Performance and Image Enhancing Peptides

May 04, 202618 minSeason 1Ep. 242
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Summary

Dr. Ashley Bowden joins The Good GP to demystify peptides, differentiating between TGA-approved medical peptides and unregulated 'research-use-only' substances promoted in fitness circles. The discussion delves into the varied demographics of users, from gym-goers to young adults influenced by social media, highlighting the scarcity of robust evidence for unregulated peptides and the associated health risks, including injection complications and unknown product contents. A key focus is a practical, non-judgmental harm-minimisation approach for GPs to build rapport, monitor patients, and support their overall health when discussing peptide use.

Episode description

In this episode, host Dr Krystyna De Lange is joined by Dr Ashley Bowden, ACRRM registrar and exercise science graduate, to discuss the growing interest in peptides, particularly those promoted in the fitness and wellness sectors.

Dr Ashley Bowden defines peptides as short chains of amino acids and distinguishes between regulated, TGA-approved peptides (such as insulin and GLP-1 analogues) and unregulated, research-use-only peptides commonly discussed online and in gyms. Exploring the demographics of peptide users in Australia, noting that use extends from athletes to recreational gym users, occupational groups, and young adults influenced by social media trends.

They also addressed the limited evidence for the efficacy and safety of unregulated peptides, highlighting that most claims are based on anecdotal reports rather than robust clinical trials. Associated risks include potential side effects, the dangers of unregulated products, and complications related to injection practices.

Dr Bowden provides a practical harm-minimisation approach for GPs whose patients raise questions about or disclose use of peptides. He stresses the value of a non-judgemental, curious approach to build rapport, assess risks, offer regular monitoring, and support overall patient health, while recognising the ethical complexities faced when evidence is lacking.

Links & Resources:


The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

Transcript

Intro / Opening

🎵 Music

C

Hello and welcome to another episode of The Good GP. My name is Christina Delange and I would like to begin today's episode by acknowledging the traditional owners of the lands upon which this podcast is being recorded. For today's episode I am recording on the lands of the Turbul and Yagura people, and my guest is joining me from the lands of the Yuan people. We pay our respects to elders, past, present, and emerging.

On today's episode of The Good GP, I am joined by Dr. Ashley Bowden to discuss the emerging world of peptides. Dr. Bowden is a current Akron Registrar working on the south coast of New South Wales. His pre medicine background includes a Bachelor of Science in Sport and Exercise Science, and he is passionate about physical activity and the outdoors.

A great combination to be able to bring a strong interest in lifestyle-based interventions to the general practice consult room. Welcome to the pot, Ashley.

B

Good morning. Thanks for the wonderful introduction.

Defining Peptides: Regulated vs. Unregulated

C

So Ash, look, I wanted to start off by asking you about what peptides are. We are beginning to hear more about them in the fitness and wellness industries. So do you want to b start off by explaining what they are and I guess how those peptides that are being promoted online for example, on social media platforms, might differ from the TGA approved peptides that we are actually using in clinical practice.

B

Of course. So peptides aren't a new concept. And like a lot of things, they've been given this almost marketing spin where a lot of people are referring to peptides not really understanding what they are. And at the absolute base, they're a short chain of amino acids. And they're used in our body as a signaling molecule to upregulate or downregulate certain things. The most common example that we'll all be familiar with is insulin and

That I think in itself is pretty interesting. We all know about insulin, but no one's calling it a peptide, and we're not branding or marketing it as such. And there's other examples as well, including the newer GLP one analogs. And so these are peptides too. Where the big difference is that often the peptides that are being referred to on social media or in the gym or out and about are these research use only peptides. So these are new drugs, medications,

Chemicals that are being tested because they're thought to have a benefit, but they're not regulated and they're not TGA approved. In fact,

almost all of them are very far from that stage. They're very early in the research. And I think that's when people refer to peptides. Often what they're talking about are these substances which haven't been researched to the degree that we, especially as doctors, would be able to then trust that they're safe, that they do what we think they do and that we understand the side effects. and the sort of impacts they could have at different people with different conditions.

Peptide Users and Their Motivations

C

So Ash, you've started to take a bit of interest in this because you've had patients and even people you're aware of outside of the clinic. or consulting room, taking or using peptides or at least looking into it. So in your experience, who's actually using these products and how are patients in Australia accessing them?

B

That's the fascinating part of this. And I think I first come across peptides in the space of performance and image-enhancing drugs. And so before peptides, people were talking about steroids or anabolics. And because I'm interested in physical activity and myself use the gym and go to CrossFit gyms, I would soon be talking to coaches who would then ask the questions because they'd either have clients or they themselves had maybe used.

anabolic steroids or peptides, or at least we're hearing about it. And so the main thought is that this is for elite athletes. Most people think that the performance enhancing drugs space is elite athletes only. And the reality is that actually it recreational gym goers. They're probably the largest group of people using it. But there's also the occupational group. There's models and even

Hard working laborers that feel their bodies getting beaten up and think they need something to help recover better. And with that as well, there's people that are aging and sort of look for peptides or steroids or a medication for the vitality aspect. So the anti aging thing. And then sadly, there's also young adults and teenagers that are seeing social media there's this term look maxing or looks maxing where they're sort of being encouraged to use

supplements or medications or drugs to get bigger, stronger, change their look, change their skin, different things like that. So there's quite a few different areas, different groups that are being exposed to peptides. And that's when they then turn to someone and ask the question, what are these? Are they safe to use? Does it do what it says on the tin?

And initially I got asked that question in a gym, but increasingly I get asked that question in the consultation room now as well. And I think that's probably why this is so important, because I'm certainly not the only GP that's being asked about peptides or about anabolic steroids or about these different drugs that might improve their strength or their recovery or their aging or their skin.

Evidence Gaps and Peptide Risks

C

Okay, so what does the current evidence actually say then about the benefits and I guess importantly the risks as well of these non-approved, non-regulated peptides?

B

So speaking specifically of the unregulated peptides, and just for your listeners that may not have heard of some of these, so things like BPC one hundred five seven, T B five hundred, there's lots of different names of these peptides. There's a huge gap between what is being promoted and sort of marketed, the desired effect, and where the actual evidence is.

If we take the peptides that are more associated with tissue healing, one of the most common is BPC157. And so this is a peptide found in human gastric juice. and there's a lot of enthusiasm, I say, that it's improves tendon and ligament soft tissue healing, but there's very limited human evidence. The majority of these peptides have probably not even got to phase one clinical trials. So those human trials.

But then there's a big pool of anecdotal I yeah, I don't want to use the word evidence, but because there are so many people using these, there ends up being this sort of pool of data that we can't really rely on. where people are saying, Oh, I've used it and it made my back pain go away, or I used this peptide and I was so much stronger and I was able to do so much more. And I think that's the evidence I say in quotations that

people are actually leaning on more. And especially in today's day and age where We've got search engines online that actually are just taking information from Reddit and online forums. That's the sort of evidence or information, I guess, that people are relying on more because the evidence that we would use.

that stronger clinical trials, randomized controlled trials just isn't there when it comes to these unregulated peptides. At most they're still in phase two, phase three trials and those are the ones that are actually the weight loss medications of which we've seen the newer GLP ones that have actually come and been approved by the TGA. So the other ones, the tissue healing, the vitality, the skin changes, really just don't have the evidence that we could trust.

C

And so I guess that follows on to the risks as well. Like we don't have the evidence for their efficacy and we don't really understand truly what the risks with these medications are. Is that correct in saying that?

B

Yeah, that's definitely correct. There's sort of two sides to this, and one is the evidence isn't there to say whether it's safe or unsafe. And so there's a lot of enthusiasm because there's nothing saying it's unsafe. I think people have taken that and run with it and there's a potential benefit and they've not heard of any harm. Now, uh there are a few cases here and there where people have seen clinicians have seen liver toxicity. There's definitely potential risks and so with the skin

Peptides, the ones that thought to enhance tanning, they've been shown to potentially increase moles. And so whether there's a cancer risk associated with this. And these are medications or drugs that were actually focused on trying to improve cancer risk, but until we've seen sufficient data, we don't know whether those new moles that are a potential side effect are are high risk.

There's certainly safety concerns, but because of the lack of evidence, it's really hard to point to one thing or another. The other thing that's often not talked about is that The way these peptides are used is often as an intramuscular or a subcutaneous injection. And so just that in itself is a risky way of giving medication, whether people are using clean needles, whether they are getting infections at the infection site.

whether they know how to inject and aren't causing damage locally. There's so many other risks to this. And on top of that, one of the biggest ones is if this is an unregulated product, how does the person that

managed to acquire it, know that what they have in front of them is the peptide they were after. We know that things could be cut with something else. Is it baby powder in front of you or is it something else? And so there's a lot of Harms that are actually not specific to the peptide itself, but to do with the broader use of them and the unregulated nature of it.

C

I won't digress too much, but the ethics of this c I it just blows my mind, especially this kind of idea of What we now face with direct-to-consumer advertising essentially is what happens with social media, which is something I think we've been lucky in Australia to avoid with very heavily regulated medicine space.

But it is our reality, I think, now. And this it's yeah, it's mind boggling and a little bit scary to think. Let's keep on going though. I wanna talk practically about how to approach this, because this is really what this episode is about.

GPs: Handling Peptide Inquiries

As a GP, if we have a patient that comes in asking us about starting peptides, how do we approach that conversation?

B

I think you're right. This is exactly where I have had colleagues ask me, what do we do? Because it's a really uncomfortable new space. And when we don't know about the product or drug or whatever it is that the person's telling us, that can feel really uncomfortable because as doctors, we're usually the one that's in the know and that can then help and educate the person in front of us. And that script is sort of flipped when the patient comes to us and says

I know everything about this. I've done all the research and my friend's been using it and it's helped them. But that's also not new. Patients have often talk to doctors about drugs that they've used, illicit drugs, illegal habits, or something that they've heard, whether it's Himalayan salt or something that they think is shown to be beneficial. And so it really falls into that space of this is a unproven, unregulated product. And

How we approach that, it can be really uncomfortable. I think a lot of people feel that they need to say, no, this is a bad idea, and tell the person in front of them, don't do it.

when in actual fact they've usually done a lot of thinking, research, spoken to plenty of people before it's come up in conversation with their doctor. And so I believe the best approach is one of being curious, no judgment, building a rapport with the patient and being inquisitive, maybe letting them teach you about it, being wary that what they

think maybe evidence, maybe less evidence or less solid evidence at least. And with that you can then start to explore what the risk might be. And as we've talked about, the risk can include how they use this drug or where they've got this drug from and whether it is actually what they think it is.

whether there's any testing that we can do to check whether it's baseline, kidney and liver function, and importantly also check in with their mental health, because that's a huge aspect of their health that will be linked to why, first of all, that they're actually seeking this drug. But also we know that some performance enhancing drugs play a huge role in mental health and can cause

aggression or deteriorating mental health. So I think it's our role as a GP to try and rein in that judgment and rein in the advice giving, especially in this unknown area. be inquisitive and then start to explore it. And maybe if we were on the same side, we can then say, Hey, look, if this was me, I think I'd feel really hesitant because we don't know enough.

C

Yeah, okay. And so I guess in the other clinical scenario would be a patient actually disclosing that they've already started taking peptides.

GPs: Supporting Patients Using Peptides

I guess how can we respond and, you know, what can we do to support them in that situation?

B

So similarly it's this harm minimization approach and this patient in front of you that has started using a peptide hasn't done so on a whim. I think it'd be really foolish to think that we can bring all the evidence and start showing them. If anything, they will probably be part of a online community or a in-person gym community, and they feel that they've got all of the information they need to know about this.

And so there's often this idea that actually the GPs don't know what they're talking about when it comes to these new peptides and these performance enhancing drugs. And so again, being non judgmental, being curious, asking them what they can tell you about it, and then offering our medical advice, which would be, how can I keep you as healthy as possible?

Can we do some tests? Can we have some check-ins? Can I see you more regularly to make sure you're going okay? Often people will cycle peptides. And so they may use it for a certain period of time. Now, that can be because it costs a lot of money and so they can only buy a certain amount and they use it for four weeks until it's gone. Or it may be that's a recommendation, which I could digress on that as

crazy in itself that there could be a recommendation on something when we don't know doses or durations. But what you can then offer is maybe we do a before and after check-in and we do some blood tests before and after and again check in on mental health. And I think at least through that non-judgmental harm minimization approach, we can build rapport. And I've had patients who on the sort of fifth, maybe sixth visit, have said to me,

What do you think? Is this a good idea? And they really feel now invested that I'm on their side and gives you an opportunity to say, actually I I wouldn't do this. I think this is unsafe. I want to support your health, but I think this is a bad idea.

And that can be impactful at that point, not at the beginning. I think at the beginning it's a how can I support you to be as safe as possible and maybe down the line we can approach it like we would with other lifestyle behaviors and that sort of motivational interviewing, checking when they're ready and seeing when we can intervene maybe a bit later.

Ethical Complexities and Future Practice

C

Well, Ash, this has been a really fascinating discussion. I think, you know, most of the time I'm having conversations on this podcast about very evidence-based recent guideline changes and evidence-based medicine. So this is an interesting kind of ethical discussion around something that isn't yet or doesn't yet have that evidence base around it and like I said, can form a bit of discomfort in the consult room. So

Thanks, Ash, for helping to enlighten us as GPs, especially for some of us who haven't had as much experience or seen this coming up as much. I think it is definitely around and that's definitely around to stay for a while. So a really helpful conversation. Appreciate your time on the good GP today.

B

Wonderful. Thanks for having me, it's been fantastic.

🎵 Music

A

If you have any questions.

🎵 Music

D

The content of this podcast represents the opinions of the good GP, hosts, and guests of the show. The content is aimed at general practitioners working in the Australian context and is not intended to represent medical advice. Any listeners experiencing symptoms or who have concerns.

🎵 Music

D

The information shared is accurate and up to date at the time of recording but welcome. We recommend all health professionals review local and up to date.

This transcript was generated by Metacast using AI and may contain inaccuracies. Learn more about transcripts.
For the best experience, listen in Metacast app for iOS or Android